Dermatology Search
Dermatology Dermatology
scleroderma
SCLERODERMA
Scleroderma is a connective tissue disorder characterized by skin thickening and fibrosis. It is rare, autoimmune and chronic.
It has an idiopathic cause and not contagious.
Early microvascular damage, mononuclear cell infiltrates and slowly developing fibrosis are the important features of the tissue lesions.
The leading causes of death are pulmonary fibrosis and pulmonary arterial hypertension.
Drug Information

Indication: Erectile dysfunction.

Indication: Erectile dysfunction.

Indication: CHD: Chronic stable angina pectoris; HTN.

Indication: Erectile dysfunction.

Indication: Acute & chronic rheumatic fever, RA, bronchial asthma, myositis, dermatitis.

Bufencon
betamethasone dipropionate + betamethasone disodiu...

Indication: Rheumatic disorders, collagen disease, allergic states.

Diprospan
betamethasone dipropionate + betamethasone disodiu...

Indication: Adjunctive treatment of acute & chronic corticosteroid-responsive disorders.

Indication: Erectile dysfunction.

Indication: Erectile dysfunction.

Indication: Class II & III pulmonary arterial HTN in adult patients. Primary pulmonary & pulmonary HTN associated ...

1  /  3
1  /  3
Editor's Recommendations
Most Read Articles
Trifarotene cream effective for face, trunk acne
28 May 2019
Trifarotene is safe, well-tolerated and effective in treating both facial and truncal acne, according to two phase III trials.
Antinuclear antibody negativity ups risk of malignancy in adult-onset dermatomyositis
08 May 2019
Antinuclear antibody (ANA) negativity appears to increase the likelihood of developing malignancy in patients with adult-onset dermatomyositis (DM) within 3 years of diagnosis of their DM, according to a recent study.
Ablative fractional CO2 laser effective for burn scars
20 May 2019
Three treatments of ablative fractional CO2 laser (AFCO2L) yield improvements in burn scar pain, itch and dermal architecture 6 weeks after treatment, a recent study has found.
Inflammatory eruptions tied to immune checkpoint inhibitors
11 Apr 2019
Immune checkpoint inhibitor therapy may lead to various inflammatory reactions with differing degrees of severity, suggests a recent study. Most rashes respond to topical treatment, but immunotherapy is often interrupted by immunobullous and exfoliative presentations.